Drugs that suppress the immune system in order to treat inflammatory bowel disease (IBD), such as Imuran, could increase the risk of skin cancer, according to the findings of two new studies. …
Federal drug regulators are receiving an increasing amount of blood cancer reports from users of some drugs designed to treat inflammatory bowel disease (IBD). …
A new U.S. study suggests that some drugs used to treat inflammatory bowel disease (IBD) and Crohn’s disease, such as Imuran and Azasan, could increase the risk of skin cancer in patients. This follows a study released last week from French researchers that found the medications, known as thiopurine drugs, could increase the risk of cancer from viral infection.…
The results of a new French study suggest that thiopurine drugs, which are commonly used to treat inflammatory bowel disease (IBD), could increase the risk of cancer from viral infections.…
